PAMG
ALXN

Patton Albertson Miller Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Patton Albertson Miller Group’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12,411
Closed -$2.28M – 245
2021
Q2 		$2.28M Sell
12,411
-18
-0.1% -$3.09K 0.52% 70
2021
Q1 		$1.9M Buy
12,429
+365
+3% +$56.5K 0.46% 72
2020
Q4 		$1.89M Buy
12,064
+294
+2% +$37.8K 0.45% 73
2020
Q3 		$1.35M Sell
11,770
-524
-4% -$56.5K 0.38% 79
2020
Q2 		$1.38M Buy
12,294
+360
+3% +$38.2K 0.4% 80
2020
Q1 		$1.07M Buy
11,934
+3,191
+36% +$313K 0.36% 91
2019
Q4 		$946K Sell
8,743
-4,443
-34% -$475K 0.25% 112
2019
Q3 		$1.29M Buy
13,186
+1,154
+10% +$130K 0.37% 96
2019
Q2 		$1.32M Buy
+12,032
New +$1.55M 0.38% 90

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Patton Albertson Miller Group's ALXN Position: Q3 2021 in Review

Patton Albertson Miller Group sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 12,411 shares — an estimated $2.28M sold.

Patton Albertson Miller Group first reported a position in ALXN in Q2 2019 and held it in 9 quarters. The position peaked at $2.28M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Patton Albertson Miller Group reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Patton Albertson Miller Group sold 12,411 Alexion Pharmaceuticals shares in Q3 2021, an estimated $2.28M.
  • Patton Albertson Miller Group first reported a position in Alexion Pharmaceuticals in Q2 2019 and held it in 9 quarters.
  • Patton Albertson Miller Group's Alexion Pharmaceuticals position peaked at $2.28M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Patton Albertson Miller Group's 13F filing for Q3 2021, filed 27 Oct 2021.